MARZARO, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.233
AS - Asia 2.489
EU - Europa 1.997
AF - Africa 620
SA - Sud America 565
OC - Oceania 49
Continente sconosciuto - Info sul continente non disponibili 29
Totale 11.982
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.911
SG - Singapore 709
IT - Italia 610
CN - Cina 609
BR - Brasile 376
HK - Hong Kong 309
FI - Finlandia 174
VN - Vietnam 172
DE - Germania 167
PL - Polonia 117
SE - Svezia 102
NL - Olanda 82
FR - Francia 76
RU - Federazione Russa 76
GB - Regno Unito 71
IN - India 56
AT - Austria 43
ZA - Sudafrica 38
CH - Svizzera 36
UA - Ucraina 35
IQ - Iraq 34
KR - Corea 29
TR - Turchia 29
CI - Costa d'Avorio 28
IE - Irlanda 28
ID - Indonesia 27
GR - Grecia 26
AR - Argentina 25
CA - Canada 24
IR - Iran 24
JP - Giappone 24
MX - Messico 24
PA - Panama 24
CZ - Repubblica Ceca 23
MD - Moldavia 23
TT - Trinidad e Tobago 23
VE - Venezuela 23
ES - Italia 22
GF - Guiana Francese 22
NI - Nicaragua 22
PY - Paraguay 22
AO - Angola 21
IL - Israele 21
SA - Arabia Saudita 21
TJ - Tagikistan 21
AM - Armenia 20
AZ - Azerbaigian 20
CV - Capo Verde 20
MN - Mongolia 20
RS - Serbia 20
BB - Barbados 19
CR - Costa Rica 19
EC - Ecuador 19
LB - Libano 19
LY - Libia 19
MW - Malawi 19
PH - Filippine 19
PK - Pakistan 19
UY - Uruguay 19
CO - Colombia 18
DO - Repubblica Dominicana 18
GE - Georgia 18
JO - Giordania 18
KH - Cambogia 18
PS - Palestinian Territory 18
PT - Portogallo 18
TN - Tunisia 18
AE - Emirati Arabi Uniti 17
LC - Santa Lucia 17
MR - Mauritania 17
NP - Nepal 17
RO - Romania 17
RW - Ruanda 17
UZ - Uzbekistan 17
ZM - Zambia 17
BE - Belgio 16
BO - Bolivia 16
GM - Gambi 16
HU - Ungheria 16
KE - Kenya 16
MY - Malesia 16
UG - Uganda 16
YE - Yemen 16
CD - Congo 15
EE - Estonia 15
EG - Egitto 15
GA - Gabon 15
HN - Honduras 15
JM - Giamaica 15
LA - Repubblica Popolare Democratica del Laos 15
MU - Mauritius 15
MZ - Mozambico 15
PE - Perù 15
SK - Slovacchia (Repubblica Slovacca) 15
SO - Somalia 15
TZ - Tanzania 15
XK - ???statistics.table.value.countryCode.XK??? 15
AD - Andorra 14
AF - Afghanistan, Repubblica islamica di 14
BS - Bahamas 14
Totale 11.310
Salva come PNG Salva come JPEG
Città #
Fairfield 778
Ashburn 609
Ann Arbor 531
Woodbridge 506
Singapore 445
Chandler 374
Houston 374
Hong Kong 295
Wilmington 285
Cambridge 279
Seattle 249
Beijing 225
Santa Clara 155
Boardman 142
Padova 133
Jacksonville 108
Princeton 103
Munich 96
Des Moines 90
Bytom 86
Medford 77
Helsinki 74
San Diego 68
Dong Ket 67
Nanjing 53
New York 50
Roxbury 49
Los Angeles 47
Ho Chi Minh City 35
Turku 35
Milan 33
Shenyang 30
Vienna 29
Abidjan 28
São Paulo 28
Buffalo 24
Chicago 21
Dublin 21
Baku 20
Dushanbe 20
Hefei 20
Luanda 20
Managua 20
Panama City 20
Athens 19
Hanoi 19
Washington 19
Brooklyn 18
Phnom Penh 18
Ulan Bator 18
Amman 17
Castries 17
Kigali 17
Nouakchott 17
Praia 17
Bridgetown 16
Kampala 16
Lusaka 16
Montevideo 16
Baghdad 15
Libreville 15
Nanchang 15
San José 15
Tashkent 15
Andorra la Vella 14
Brescia 14
Cagliari 14
Cape Town 14
Cayenne 14
Guangzhou 14
Jinan 14
Lilongwe 14
L’Aquila 14
San Francisco 14
Stockholm 14
Tallinn 14
Tripoli 14
Vicenza 14
Warsaw 14
Accra 13
Dar es Salaam 13
Hebei 13
London 13
Nassau 13
Rio de Janeiro 13
Yerevan 13
Bishkek 12
Boston 12
Chisinau 12
Cotonou 12
Dakar 12
Dili 12
Kinshasa 12
Nairobi 12
Podgorica 12
Rome 12
Vientiane 12
Zurich 12
Antananarivo 11
Florence 11
Totale 7.554
Salva come PNG Salva come JPEG
Nome #
The ISOLPHARM project: ISOL-based production of radionuclides for medical applications 274
Corilagin Induces High Levels of Apoptosis in the Temozolomide-Resistant T98G Glioma Cell Line 214
Early Evaluation of Copper Radioisotope Production at ISOLPHARM 198
Quinazoline-based multi-tyrosine kinase inhibitors: synthesis, modeling, antitumor and antiangiogenic properties 192
A NEW PRODUCTION METHOD OF HIGH SPECIFIC ACTIVITY RADIONUCLIDES TOWARDS INNOVATIVE RADIOPHARMACEUTICALS: THE ISOLPHARM PROJECT 188
Substituted quinazolinones as kinase inhibitors endowed with anti-fibrotic properties 187
Using the TOPS-MODE approach to fit multi-target QSAR models for tyrosine kinases inhibitors 180
A novel convenient synthesis of benzoquinazolines 178
Targeting kinases with anilinopyrimidines: Discovery of N-phenyl-N'-[4-(pyrimidin-4-ylamino)phenyl]urea derivatives as selective inhibitors of class III receptor tyrosine kinase subfamily 177
A microwave improvement in the synthesis of the quinazoline scaffold 176
A new access to quinazolines from simple anilines 171
Design, synthesis and biological evaluation of novel trimethylangelicin analogues targeting nuclear factor kB (NF-kB) 168
Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β(0)-Thalassemia Families with High Fetal Hemoglobin Levels 167
Novel benzoquinoline derivatives via unpredicted condensation of ethyl propiolate and naphthylamines: Synthesis and topoisomerase inhibition activity 167
The Importance of Descriptor-Based Clusterization in QSAR Models Development: Tyrosine Kinases Inhibitors as a Key Study 162
Psoralen Derivatives as Inhibitors of NF-κB/DNA Interaction: Synthesis, Molecular Modeling, 3D-QSAR, and Biological Evaluation 161
Targeting DNA Binding for NF-κB as an Anticancer Approach in Hepatocellular Carcinoma 159
New Vandetanib analogs: fused tricyclic quinazolines with antiangiogenic potential. 157
Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib 156
Psoralenquinones as a Novel Class of Proteasome Inhibitors: Design, Synthesis and Biological Evaluation 149
Synthesis and antitumor activity of novel amsacrine analogs: the critical role of the acridine moiety in determining their biological activity 143
Preliminary evaluation of the production of non-carrier added 111Ag as core of a therapeutic radiopharmaceutical in the framework of ISOLPHARM_Ag experiment 143
Preliminary Study of a 1,5-Benzodiazepine-Derivative Labelled with Indium-111 for CCK-2 Receptor Targeting 141
A Novel Aza-Derivative Inhibits agr Quorum Sensing Signaling and Synergizes Methicillin-Resistant Staphylococcus aureus to Clindamycin 141
Pyrroloquinolinone-based dual topoisomerase I/II inhibitor 139
Improved Trimethylangelicin Analogs for Cystic Fibrosis: Design, Synthesis and Preliminary Screening 136
Discovery Of Biarylaminoquinazolines As Novel Tubulin Polymerization Inhibitors 136
Investigational drugs targeting cyclin-dependent kinases for the treatment of cancer: an update on recent findings (2013-2016) 135
Autogrid-based clusterization of kinases: selection of representative conformations for docking purposes 134
Tyrosine kinase inhibitor prodrug-loaded liposomes for controlled release at tumor microenvironment 132
A novel approach to quinazolin-4(3H)-one via quinazoline oxidation: an improved synthesis of 4-anilinoquinazolines 131
Development of a Novel Furocoumarin Derivative Inhibiting NF-kB Dependent Biological Functions: Design, Synthesis and Biological Effects 129
Exploring Epidermal Growth Factor Receptor (EGFR) Inhibitor Features: The Role of Fused Dioxygenated Rings on the Quinazoline Scaffold 128
Photobiological properties of 3-psoralenacetic acids 126
Benzoquinazoline derivatives as new agents affecting DNA processing. 125
Microwave-promoted mono-N-alkylation of aromatic amines in water: a new efficient and green method for an old and problematic reaction 124
Molecular mechanism of action of trimethylangelicin derivatives as CFTR modulators 124
Photochemical and photobiological studies on furoquinazolines as new psoralen analogs 123
Progetto Isolpharm_Ag: produzione di 111Ag e progettazione di radiofarmaci a scopo terapeutico 123
Synthesis and evaluation of tricyclic quinazoline derivatives as egfr inhibitors 122
Synthesis and evaluation of erlotinib analogues: exploiting ring closure 119
Differential Effects of Angelicin Analogues on NF- κ B Activity and IL-8 Gene Expression in Cystic Fibrosis IB3-1 Cells 119
Photobiological properties of 3-psoralenacetic acids 119
Multicomponent Assembly of the Kinesin Spindle Protein Inhibitor CPUYJ039 and Analogues as Antimitotic Agents 117
Known triterpenes and their derivatives as scaffolds for the development of new therapeutic agents for cancer 115
Targeting kinases with anilinopyrimidines: discovery of N-phenyl-N’-[4-(pyrimidin-4-ylamino)phenyl]urea derivatives as selective inhibitors of Type III receptor tyrosine kinase subfamily 114
Synthesis of novel psoralen derivatives as inhibitors of NF-kB dependent biological function 112
Sintesi e purificazione dei precursori di desossiCBD per formulazioni innovative per cannabinoidi 112
QSAR and 3D-QSAR Models in the Field of Tubulin Inhibitors as Anticancer Agents 111
Quinazoline derivatives as potential anticancer agents: a patent review (2007 – 2010) 111
Surface plasmon resonance based analysis of the binding of LYAR protein to the rs368698783 (G>A) polymorphic Aγ-globin gene sequences mutated in β-thalassemia 110
A novel phenolic derivative inhibits AHL-dependent Quorum Sensing signaling in Pseudomonas aeruginosa 109
Preliminary Discovery of Small Molecule Inhibitors of Epidermal Growth Factor Receptor (EGFR) That Bind to the Extracellular Domain 108
Psoralen derivatives as inhibitors of NF-κB/DNA interaction: the critical role of the furan ring 107
Quinazoline-based kinase inhibitors: new synthetic approach and biological evaluation. 106
Chinazoline benzosostituite: sintesi convenzionale vs. sintesi assistita da microonde. 104
Psoralen derivatives as NF-kB/DNA interaction inhibitors: structural insight into the binding mode 104
Synthesis of small molecule-based ligands for active targeting of CCK2R for the ISOLPHAR-Ag project 103
Development of transdermal delivery systems for innovative clinical applications of cannabinoids 103
Lejeuneaceae (Marchantiophyta) from a species-rich taphocoenosis in Miocene Mexican amber, with a review of liverworts fossilised in amber 102
4-Anilinoquinazolines endowed with antiangiogenic activity 100
6-Arylpyrimidines as novel attractive scaffolds for ATP competitive KSP inhibition 98
Structure-Based Drug Design and Combinatorial Chemistry in the Search of Antimitotic Agents 97
Benzochinazoline: nuovo approccio sintetico 96
The Moss Macromitrium Richardii (Orthotrichaceae) with Sporophyte and Calyptra Enclosed in Hymenaea Resin from the Dominican Republic 96
SAM50, a side door to the mitochondria: The case of cytotoxic proteases 95
Effects of analogues of 4,6,4'-trymethylangelicin on erythroid differentiation and NF-kB activity. 94
New benzoquinazoline derivatives as antitumor agents 94
Toward novel sulphur-containing derivatives of tetraazacyclododecane: Synthesis, acid-base properties, spectroscopic characterization, DFT calculations, and cadmium(ii) complex formation in aqueous solution 94
Biphenylaminoquinazolines as novel dual inhibitors of tyrosine kinases and tubulin polymerization: synthesis, SARs and anticancer properties 93
Biphenyl tricyclic quinazoline compounds 93
Discovery of Novel Quinazolinone Based mTOR Inhibitors Endowed with Antifibrotic Properties 92
Sviluppo di sistemi per la veicolazione transdermica di cannabinoidi 92
Furochinazoline come potenziali bioisosteri di furocumarine: sintesi e proprieta’ fotobiologiche 90
FB-Qsar based developement of novel potent Tyrosine-Kinase Inhibitors 88
Furoquinazolines as furocoumarin analogs: can we improve solubility without impairing biological activity? 88
Discovery of novel wtRET and V804MRET inhibitors: from hit to lead 88
Psoralenquinone proteasome inhibitors: design, synthesis and biological evaluation 87
VESICULAR TRANSDERMAL DELIVERY SYSTEMS FOR CANNABINOIDS 87
ETHOSOMAL GEL FORMULATIONS FOR THE TRANSDERMAL DELIVERY OF CANNABINOIDS 85
Oleocanthalic acid improves MASH features via a NOX1-dependent mechanism 84
New topoisomerase inhibitors as proapoptotic agents 84
Dual kinase targeting in leukemia 84
Assessing the interaction between hemoglobin and the receptor binding domain of SARS-CoV-2 spike protein through MARTINI coarse-grained molecular dynamics 83
Productionvof carrier-free copper radionuclides with the ISOLPHARM method for nuclear medicine 83
sintesi e studio di polieterocicli azotati ad attività antitumorale 82
N-acyl-omega-aminoacid ethanolamides resembling anandamide structure: synthesis and biological evaluation. 81
Synthesis and purification of desoxy-CBD precursors for innovative pain therapy formulations 79
ISOLPHARM_Ag Project: from the production of the the radioisotope 111Ag to the design of a radiopharmaceutical 78
ISOLPHAR_Ag Project:: production and purification of silver ion beams for 111Ag production. 78
Development and Validation of Novel Z-360-Based Macromolecules for the Active Targeting of CCK2-R 77
Biological evaluation of psoralen derivatives as inhibitors of NF-kappa B/DNA interaction: molecular modeling, 3D-QSAR, EMSA assays and inhibition of IL-8 gene expression. 77
Synthesis and characterization of novel possible bifunctional chelators for Silver-111 in the ISOLPHARM_Ag project 77
Proteolysis Targeting Chimeric Molecules: Tuning Molecular Strategies for a Clinically Sound Listening 74
Synthesis and Biological Evaluation of Pyrazole-Pyrimidones as a New Class of Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) 74
Deformable Vesicles with Edge Activators for the Transdermal Delivery of Non-Psychoactive Cannabinoids 73
From single to multi-target kinases inhibitors: using the old-age kinases inhibitors data to face the new-age 73
Aged Garlic Extract (AGE) and Its Constituent S-Allyl-Cysteine (SAC) Inhibit the Expression of Pro-Inflammatory Genes Induced in Bronchial Epithelial IB3-1 Cells by Exposure to the SARS-CoV-2 Spike Protein and the BNT162b2 Vaccine 73
Inibitori multitirosinchinasi utili per le patologie correlate: modelli farmacoforici, composti identificati tramite questi modelli, metodi per la loro preparazione, la loro formulazione e il loro impiego terapeutico 67
Effects of Sulforaphane on SARS‑CoV‑2 infection and NF‑κB dependent expression of genes involved in the COVID‑19 ‘cytokine storm’ 60
Totale 11.809
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.555
article - articoli 28.986
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 504
selected - selezionate 0
volume - volumi 0
Totale 69.045
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021782 0 0 0 55 31 63 17 82 147 150 105 132
2021/20221.094 33 180 101 89 80 58 44 113 46 27 73 250
2022/2023920 179 64 17 97 148 140 10 77 100 16 47 25
2023/2024753 31 86 94 57 55 125 44 63 21 34 75 68
2024/20252.499 28 127 119 122 350 62 131 150 242 92 420 656
2025/20263.265 576 784 1.252 653 0 0 0 0 0 0 0 0
Totale 12.083